Received Sep 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 4L454 | — |
administered by accident Kinrix to 2 patients that are 15 month old; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 15-month-old male patient who received DTPa-IPV (Kinrix) (batch number 4L454, expiry date 16-OCT-2026) for prophylaxis. Previously administered products included Pediarix (Dose given on June 28th 2024, batch number 9P329, expiry date March 6th 2026), Pediarix (Dose given on August 30th 2024, batch number X9ET5, expiry date March 9th 2026) and Pediarix (Dose given on October 29th 2024, batch number 5YB7L, expiry date November 29th 2026). On 08-AUG-2025, the patient received Kinrix. On 08-AUG-2025, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: administered by accident Kinrix to 2 patients that are 15 month old). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 18-AUG-2025 Nurse explained that on August 8th 2025 she administered by accident Kinrix to 2 patients that are 15 month old which led to inappropriate age at vaccine administration.; Sender's Comments: US-GSK-US2025106259:same reporter,different patient